📅 *Schedule your free 30-min strategy call with Catherine:* https://bit.ly/3LTqiBw
⚙️ *Restart your practice in 7 days:* https://bit.ly/46Gwaaa
⬇️
Hello, and welcome to Beauty and the Biz where we talk about the business and marketing side of plastic surgery, and selling but staying in your practice.
I’m your host, Catherine Maley, author of Your Aesthetic Practice – What your patients are saying, as well as consultant to plastic surgeons, to get them more patients, more profits and stellar reputations. Now, today’s episode is called “Selling but Staying in Your Practice — with Andrew Kaufman, MD”.
This week’s Beauty and the Biz Podcast is an interview with Dr. Andrew Kaufman, a board-certified dermatologist specializing in Mohs, dermatologic and cosmetic surgery in Thousand Oaks, CA for over 28 years.
He built a nice size practice with several doctors under him plus 40 staff and a lot of accounts receivable.
And, like others who have put decades into building their practices, he was searching for an exit plan that made financial and emotional sense to him.
Dr. Kaufman recently sold his practice to a big private equity derm group known as Forefront Dermatology so we talked about the specifics of that transaction.
We discussed:
Why he was ready to sell What made his practice attractive to buy How his associates and staff reacted What it’s like to sell yet stay in the practice as an employee He offered great advice on how to set yourself up to sell, how much time it takes to prepare and who to get help from to negotiate the best scenario for you.
Visit Dr. Kaufman’s website P.S. Please review!
📲 If you’re thinking about making a change and could use a different perspective, let’s talk. Schedule a Free 30-Minute strategy call with me at: https://bit.ly/3LTqiBw
✔️ STAY UPDATED!
Website: https://bit.ly/31O4DHp Blog: https://bit.ly/31HmEHx Podcast: https://bit.ly/3DMIHJN Videocast: https://bit.ly/3DNLjXL Apple Podcasts: https://apple.co/3pGyY2o 🤝 LET’S CONNECT! 🤝
Instagram: https://bit.ly/3GynMvz Facebook: https://bit.ly/3IJxL35 Twitter: https://bit.ly/3GxJUGy LinkedIn: https://bit.ly/3lWoYRM
source